The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group
Abstract
Purpose: To determine whether fluoxetine improves overall quality of life (QOL) in advanced cancer patients with symptoms of depression revealed by a simple survey. Patients and Methods: One hundred sixty-three patients with an advanced solid tumor and expected survival between 3 and 24 months were randomly assigned in a double-blinded fashion to receive either fluoxetine (20 mg daily) or placebo for 12 weeks. Patients were screened for at least minimal depressive symptoms and assessed every 3 to 6 weeks for QOL and depression. Patients with recent exposure to antidepressants were excluded. Results: The groups were comparable at baseline in terms of age, sex, disease distribution, performance status, and level of depressive symptoms. One hundred twenty-nine patients (79%) completed at least one follow-up assessment. Analysis using generalized estimating equation modeling revealed that patients treated with fluoxetine exhibited a significant improvement in QOL as shown by the Functional Assessment of Cancer Therapy–General, compared with patients given placebo (P = .01). Specifically, the level of depressive symptoms expressed was lower in patients treated with fluoxetine (P = .0005), and the subgroup of patients showing higher levels of depressive symptoms on the two-question screening survey were the most likely to benefit from treatment. Conclusion: In this mix of patients with advanced cancer who had symptoms of depression as determined by a two-question bedside survey, use of fluoxetine was well tolerated, overall QOL was improved, and depressive symptoms were reduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Case-finding instruments for depression: Two questions are as good as many
Whooley, M. A., Avins, A. L., Miranda, J., & Browner, W. S. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.00076.x · Cited by 1,826
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Efficacy and safety of mianserin in the treatment of depression of women with cancer
Costa, D., Mogos, I., & Toma, T. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb08081.x · Cited by 202
Cited by
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Akechi, T., Okuyama, T., Sugawara, Y., Nakano, T., Shima, Y., & Uchitomi, Y. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.149 · Cited by 536
Holland, J. C., Andersen, B., Breitbart, W. S., Buchmann, L. O., Compas, B., Deshields, T. L., Dudley, M. M., Fleishman, S., Fulcher, C. D., Greenberg, D. B., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0027 · Cited by 423
Psychiatric disorders in advanced cancer
Miovic, M., & Block, S. (2007) · Cancer · doi:10.1002/cncr.22980 · Cited by 376
Drug therapy for the management of cancer-related fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006704.pub3 · Cited by 283
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236
Pharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Li, M., Kennedy, E. B., Byrne, N., Gérin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., & Green, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4286 · Cited by 151
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158
Cancer and stress: NextGen strategies
Cui, B., Peng, F., Lu, J., He, B., Su, Q., Luo, H., Deng, Z., Jiang, T., Su, K., Huang, Y., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.005 · Cited by 152
“The SSRI fluoxetine effectively alleviates depressive symptoms of 163 advanced cancer patients based on a simple two-item questionnaire (Fisch et al., 2003).”
MethodThe prevalence and pharmacotherapy of depression in cancer patients
Ng, C. G., Boks, M. P. M., Zainal, N. Z., & de Wit, N. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.034 · Cited by 138
Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1364-z · Cited by 128
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126
Management of Depression in Patients With Cancer: A Clinical Practice Guideline
Li, M., Kennedy, E. B., Byrne, N., Gérin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., & Green, E. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.011072 · Cited by 96
Depression and end-of-life care for patients with cancer
Rosenstein, D. L. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/drosenstein · Cited by 92
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Usefulness of the nurse‐assisted screening and psychiatric referral program
Shimizu, K., Akechi, T., Okamura, M., Oba, A., Fujimori, M., Akizuki, N., & Uchitomi, Y. (2005) · Cancer · doi:10.1002/cncr.20992 · Cited by 62
The treatment of depression in patients with advanced cancer undergoing palliative care
Price, A., & Hotopf, M. (2009) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e328325d17a · Cited by 60
Okamura, M., Akizuki, N., Nakano, T., Shimizu, K., Ito, T., Akechi, T., & Uchitomi, Y. (2008) · Psycho-Oncology · doi:10.1002/pon.1213 · Cited by 46
Riblet, N., Larson, R., Watts, B. V., & Holtzheimer, P. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.05.010 · Cited by 41
Beauplet, B., Soulie, O., Niemier, J.-Y., Pons-Peyneau, C., Belhadi, D., Couffignal, C., & Fossey-Diaz, V. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05682-9 · Cited by 5
Metadata
- Authors
- Fisch, M. J., Loehrer, P. J., Kristeller, J., Passik, S., Jung, S.-H., Shen, J., Arquette, M. A., Brames, M. J., & Einhorn, L. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-05-15
- Volume
- 21
- Issue
- 10
- Pages
- 1937-1943
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2015045196
- Cited by
- 176
- References
- 4
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.